EARNINGSBijan Robinson and Baker Mayfield front Sonic's $7 Big Deal Meal in the "My Greatest 7" football-season campaignSep 18ENERGYThe New Yorker draws criticism for framing pregnancy as ambiguous in essay on early testingSep 18REGULATORYChatGPT's 0-5 NFL debut logs a 5.23-unit loss as Week 2 brings a model upgradeSep 17MODModine Manufacturing sets September 28 record date for Performance Technologies spin-off, October 1 distribution targetedSep 17JPMBen Delo loaned Nina Power more than £300,000 for a libel claim. The crypto billionaire now controls her home.Sep 17MACROMcDonald's puts value strategy to the test as turnaround path remains open for MCDSep 17CRYPTOHurricane charity scams start before storms hit, built on broker data covering 100 million householdsSep 17MACROFINRA leverage deceleration echoes signals from three prior market peaksSep 17EARNINGSHHS names eight new U.S. Preventive Services Task Force members under Kennedy overhaulSep 17DEALSUnilever faces union pushback over unequal worker protections in $44.8bn McCormick dealSep 17EARNINGSBijan Robinson and Baker Mayfield front Sonic's $7 Big Deal Meal in the "My Greatest 7" football-season campaignSep 18ENERGYThe New Yorker draws criticism for framing pregnancy as ambiguous in essay on early testingSep 18REGULATORYChatGPT's 0-5 NFL debut logs a 5.23-unit loss as Week 2 brings a model upgradeSep 17MODModine Manufacturing sets September 28 record date for Performance Technologies spin-off, October 1 distribution targetedSep 17JPMBen Delo loaned Nina Power more than £300,000 for a libel claim. The crypto billionaire now controls her home.Sep 17MACROMcDonald's puts value strategy to the test as turnaround path remains open for MCDSep 17CRYPTOHurricane charity scams start before storms hit, built on broker data covering 100 million householdsSep 17MACROFINRA leverage deceleration echoes signals from three prior market peaksSep 17EARNINGSHHS names eight new U.S. Preventive Services Task Force members under Kennedy overhaulSep 17DEALSUnilever faces union pushback over unequal worker protections in $44.8bn McCormick dealSep 17

The New Yorker draws criticism over "kind of pregnant" framing in early pregnancy essay

The New Yorker drew criticism Thursday after promoting an essay that described the binary definition of pregnancy as "misleading" and suggested a woman could be "kind of pregnant." The essay, "The Unsettling Ambiguity of Early Pregnancy," by Apoorva Tadepalli, examined what at-home pregnancy tests can and cannot tell women, grounded in the writer's experience with multiple pregnancy losses and a current pregnancy.

By Desmond ChoiNewsroomSeptember 17, 20262 min read
Share

Key takeaways

  • The New Yorker drew criticism Thursday for promoting an essay that called the binary definition of pregnancy 'misleading' and suggested a woman could be 'kind of pregnant.'
  • The essay, 'The Unsettling Ambiguity of Early Pregnancy' by Apoorva Tadepalli, drew on her experience of five positive pregnancy tests and multiple pregnancy losses, plus a current pregnancy.
  • The FDA says at-home tests detect the hormone hCG produced after a fertilized egg implants, and that a positive result gives no information about how a pregnancy will develop.
  • Critics including Elizabeth Barcohana, Lisa Cusack, and Roxanne Hoge argued that a test's technical limitations and uncertainty over viability do not change the underlying biological fact of whether a woman is pregnant.
  • The American College of Obstetricians and Gynecologists states that pregnancy begins at implantation, with viability a separate question requiring additional evaluation.

The New Yorker drew criticism Thursday after promoting an essay that described the binary definition of pregnancy as "misleading" and suggested a woman could be "kind of pregnant." The essay, "The Unsettling Ambiguity of Early Pregnancy," by Apoorva Tadepalli, examined what at-home pregnancy tests can and cannot tell women, grounded in the writer's experience with multiple pregnancy losses and a current pregnancy.

The magazine's promotion on X described at-home tests as capturing only a moment when an embryo has implanted, and said a woman might still be testing positive while being "kind of pregnant, a little bit pregnant, or almost pregnant, or maybe pregnant." That framing drew immediate pushback from several named voices who argued the language blurred a binary biological fact.

What the tests actually detect

The Food and Drug Administration says at-home pregnancy tests detect human chorionic gonadotropin, or hCG, a hormone produced after a fertilized egg attaches to the uterine wall. The agency notes that testing too early can produce inaccurate results and that a positive home test provides no information about how a pregnancy will develop. The American College of Obstetricians and Gynecologists states that pregnancy begins at implantation and that viability can require additional evaluation as development progresses.

Elizabeth Barcohana, the America First Policy Institute's California Ambassador to the America First Women's initiative, drew a clear line between those two things. Pregnancy, she said in a Thursday statement, is a physical, biological state triggered when a fertilized embryo implants and initiates a hormonal reaction. Viability is a separate question. She also argued The New Yorker's editors "betrayed the author" with the promotional framing, saying Tadepalli was writing about something "totally legitimate for women trying to start a family" and that the essay's real subject, the limits of early testing and the emotional weight that follows for women who have experienced loss, deserved a less loaded presentation.

Lisa Cusack, president of the Don't L.A. My Burbank PAC, said the piece read as "a tortured attempt to make pregnancy into a subjective experience in order to justify abortion." She argued that a test's technical limitations do not alter the underlying biological state. Roxanne Hoge, chair of the Los Angeles County Republican Party and a mother of four, made a similar point: uncertainty over whether a pregnancy will remain viable does not change whether a woman is pregnant.

Tadepalli's essay described testing positive during five pregnancies and spending time in each unsure whether she would miscarry. Those experiences, she wrote, shaped her ability to emotionally embrace her current pregnancy.

Fox News Digital reached out to The New Yorker for comment and did not receive an immediate response.

About this story

Filed by the newsroom of MarketPR on September 17, 2026. Source: foxnews.com. Indicative figures are not investment advice.

Back to the news index

Frequently asked

What did The New Yorker's promotion actually say?

Its post on X described at-home tests as capturing only the moment an embryo implants and said a woman might be testing positive while being 'kind of pregnant, a little bit pregnant, or almost pregnant, or maybe pregnant.'

What do at-home pregnancy tests detect?

According to the FDA, they detect human chorionic gonadotropin (hCG), a hormone produced after a fertilized egg attaches to the uterine wall, though testing too early can produce inaccurate results.

Who criticized the framing and what was their main argument?

Elizabeth Barcohana of the America First Policy Institute, Lisa Cusack of the Don't L.A. My Burbank PAC, and Roxanne Hoge of the Los Angeles County Republican Party argued that a test's limitations and questions of viability do not change whether a woman is biologically pregnant.

What was the essay actually about?

Written by Apoorva Tadepalli, it examined what at-home pregnancy tests can and cannot tell women, drawing on her experience testing positive during five pregnancies while unsure whether she would miscarry.

Did The New Yorker respond to the criticism?

Fox News Digital reached out to The New Yorker for comment and did not receive an immediate response.